CI Investments Inc. Sells 519,412 Shares of Kenvue Inc. $KVUE

CI Investments Inc. decreased its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 98.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,485 shares of the company’s stock after selling 519,412 shares during the period. CI Investments Inc.’s holdings in Kenvue were worth $154,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Savant Capital LLC increased its position in shares of Kenvue by 9.1% during the second quarter. Savant Capital LLC now owns 21,845 shares of the company’s stock worth $457,000 after acquiring an additional 1,826 shares in the last quarter. Vestmark Advisory Solutions Inc. lifted its position in Kenvue by 115.0% in the 2nd quarter. Vestmark Advisory Solutions Inc. now owns 47,191 shares of the company’s stock valued at $988,000 after acquiring an additional 25,245 shares in the last quarter. Wedbush Securities Inc. lifted its position in Kenvue by 14.9% in the 2nd quarter. Wedbush Securities Inc. now owns 25,221 shares of the company’s stock valued at $528,000 after acquiring an additional 3,268 shares in the last quarter. Fox Run Management L.L.C. acquired a new position in Kenvue during the 2nd quarter valued at about $1,231,000. Finally, AE Wealth Management LLC boosted its stake in Kenvue by 47.7% during the 2nd quarter. AE Wealth Management LLC now owns 23,428 shares of the company’s stock valued at $490,000 after purchasing an additional 7,571 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently commented on KVUE. Canaccord Genuity Group increased their price objective on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Wednesday, February 18th. Jefferies Financial Group cut Kenvue from a “buy” rating to a “hold” rating and cut their target price for the company from $23.00 to $18.00 in a research report on Friday, January 30th. Zacks Research upgraded Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Citigroup raised their price objective on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. Finally, UBS Group lifted their price objective on shares of Kenvue from $17.00 to $19.00 and gave the stock a “neutral” rating in a report on Wednesday, February 18th. Three research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $19.58.

Kenvue Price Performance

Kenvue stock opened at $18.41 on Monday. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17. The company’s 50 day moving average price is $17.85 and its two-hundred day moving average price is $17.40. The stock has a market cap of $35.29 billion, a P/E ratio of 23.91, a P/E/G ratio of 4.21 and a beta of 0.51. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last released its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.05. The company had revenue of $3.78 billion during the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.Kenvue’s quarterly revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.26 earnings per share. On average, equities analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were paid a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.5%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio is 107.79%.

Insider Activity

In other Kenvue news, Director Jeffrey C. Smith bought 3,200,000 shares of the firm’s stock in a transaction dated Friday, December 12th. The stock was purchased at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the transaction, the director directly owned 27,307,632 shares in the company, valued at $474,333,567.84. This trade represents a 13.27% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.17% of the stock is currently owned by corporate insiders.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.